Read original Larvik (Norway), January 10, 2025 - In reference to the press release of January 10th issued by Greater Than, accusing ABAX of infringing upon contractually regulated intellectual property (IP) rights, ABAX categorically refutes these allegations. ABAX find it necessary to address the statements made, as these claims are …
Transaction overview Date Trading Venue Volume Weighted average share price (NOK) Total daily cumulative transaction value (NOK) 02 January 25 OSE 25,000 28.7230 718,075 03 January 25 OSE 14,000 28.7935 403,109 06 January 25 OSE 15,000 28.8761 433,141 07 January 25 OSE 20,000 28.9190 578,380 08 January 25 OSE 14,000 29.1265 407,771 09 January 25 …
Nordea Bank AbpStock exchange release – Changes in company’s own shares10.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* ** Total cost, EUR* ** XHEL …
FIDELITY CHINA SPECIAL SITUATIONS PLC (the 'Company') TRANSACTION IN OWN SHARES The Board of the Company announces that it has repurchased for cancellation. Number of shares repurchased: 248,405 Date of transaction: 10 January 2025 Average share price paid per share (GBp): 213.320 Lowest share price paid per share (GBp): …
Fitch lowers Heimstaden AB’s Long-Term Issuer Default rating (IDR) to ‘B-‘ and revises the Outlook to Rating Watch Negative (RWN) from Negative. Today Fitch stated “Heimstaden AB’s RWNs reflect the execution risk of its bond issuance planned for 1Q25 together with today’s tender offer to repay bonds maturing in 2025 …
Fitch affirms Heimstaden Bostad’s Long-Term Issuer Default rating (IDR) of ‘BBB-‘ and raises the Outlook to Stable from Negative.Co-CEO Christian Fladeland comments: "The stable outlook validates that Heimstaden Bostad continues to deliver on its base case performance which includes stronger than ever operational results supported by stabilised credit metrics. …
Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the "Product"), a pharmaceutical product based on Klaria's patented alginate films for fast and reliable administration via the oral mucosa, which is approved in Germany, Spain and Italy for …
Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, …
Editorial Contact: Priya Sharma – +44 (0) 203 965 7415Company Contact: Kevin Bastian – +1 630 694 3342 Please quote the following contact information when publishing:Tel.: 540.633.3549, Fax: 540.633.0294, www.thomsonlinear.com; Thomson@regalrexnord.com 01.08.2024, DOWNERS GROVE, IL – Thomson Industries, Inc., a leading manufacturer of linear motion control solutions, has announced …
On 7 May 2024, Arise AB (below “Arise” or “the Company”) announced that the Board of Directors, based on the authorization granted by the Annual General Meeting 2024, had resolved to initiate a buyback program. Within the framework of this buyback program, ordinary shares were repurchased for a total amount of …
